L-glutamic acid derivatives
US4920125A · kind A · utility
19Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 1989 |
| Grant date | Apr 24, 1990 |
| Priority date | — |
| Expiry date | Aug 29, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pyrimidin-5-yl derivatives of L-glutamic acid are anti-neoplastic agents. A typical embodiment is N-(4-[5-(2,6-diamino-4-hydroxypyrimidin-5-yl)-butyl]-thien-2-ylcarboxy)-L- glutamic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.